DALLATOMASINA, Alice
 Distribuzione geografica
Continente #
NA - Nord America 178
EU - Europa 137
AS - Asia 46
AF - Africa 1
Totale 362
Nazione #
US - Stati Uniti d'America 176
SE - Svezia 39
IE - Irlanda 37
CN - Cina 35
IT - Italia 30
DE - Germania 13
TR - Turchia 6
FI - Finlandia 4
CH - Svizzera 3
GB - Regno Unito 3
HK - Hong Kong 3
BE - Belgio 2
UA - Ucraina 2
AF - Afghanistan, Repubblica islamica di 1
BS - Bahamas 1
CA - Canada 1
DK - Danimarca 1
EG - Egitto 1
HR - Croazia 1
IN - India 1
MD - Moldavia 1
MT - Malta 1
Totale 362
Città #
Chandler 61
Dublin 37
Ann Arbor 18
New York 14
Shanghai 9
Ashburn 8
Bremen 7
Princeton 7
Nanjing 6
Beijing 5
Parma 5
Vedelago 5
Wilmington 4
Central 3
Dearborn 3
Des Moines 3
Grafing 3
Izmir 3
Kocaeli 3
Marghera 3
Uster 3
Woodbridge 3
Brussels 2
Düsseldorf 2
Falls Church 2
Helsinki 2
Houston 2
Kunming 2
Novara 2
Verona 2
Zhengzhou 2
Andover 1
Cairo 1
Changchun 1
Dallas 1
Edinburgh 1
Fairfield 1
Frankfurt am Main 1
Haikou 1
Hebei 1
Il-Madliena 1
Jiaxing 1
Kabul 1
Lanzhou 1
Los Angeles 1
Mestre 1
Modena 1
Mumbai 1
Nassau 1
New Orleans 1
San Mateo 1
Seattle 1
Taiyuan 1
Tianjin 1
Toronto 1
Xiangfen 1
Zagreb 1
Totale 257
Nome #
Pro-apoptotic anti-NG2/CSPG4 monoclonal antibodies for disease therapy 78
Diversified expression of NG2/CSPG4 isoforms in glioblastoma and human foetal brain identifies pericyte subsets 58
Theranostic impact of NG2/CSPG4 proteoglycan in cancer 56
Structural deciphering of the NG2/CSPG4 proteoglycan multifunctionality. 55
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses for disease therapy 49
Pro-apoptotic anti-NG2/CSPG4 antibodies and their uses in disease therapy 39
Everolimus in the management of metastatic renal cell carcinoma: An evidence-based review of its place in therapy 38
Totale 373
Categoria #
all - tutte 1.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.399


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20195 0 0 0 0 0 0 0 0 0 0 4 1
2019/202032 5 0 0 0 1 3 8 2 5 5 3 0
2020/202137 0 0 0 0 2 2 0 2 19 5 0 7
2021/202243 0 6 0 3 1 3 0 3 3 3 4 17
2022/2023191 18 24 15 19 21 18 3 15 49 1 8 0
2023/202452 0 8 3 1 7 18 6 3 3 3 0 0
Totale 373